“Histiocytoses are rare diseases, and the annual incidences…are not exactly known,” revealed Ronald S. Go, MD, Associate Professor of Medicine, Mayo Clinic, Rochester, and panel chair of the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Histiocytic Neoplasms. Dr. Go presented these new guidelines at the NCCN 2021 Virtual Congress: Hematologic Malignancies.
Emile JF, Abla O, Fraitag S, et al. Revised classification of histiocytoses and neoplasms of the macrophage-dendritic cell lineages. Blood 2016;127:2672–2681.
Stålemark H, Laurencikas E, Karis J, et al. Incidence of Langerhans cell histiocytosis in children: a population-based study. Pediatr Blood Cancer 2008;51:76–81.
Goyal G, Shah MV, Hook CC, et al. Adult disseminated Langerhans cell histiocytosis: incidence, racial disparities and long-term outcomes. Br J Haematol 2018;182:579–581.
Makras P, Stathi D, Yavropoulou M, et al. The annual incidence of Langerhans cell histiocytosis among adults living in Greece. Pediatr Blood Cancer 2020;67:e28422.
Diamond EL, Dagna L, Hyman DM, et al. Consensus guidelines for the diagnosis and clinical management of Erdheim-Chester disease. Blood 2014;124:483–492.
Durham BH. Molecular characterization of the histiocytoses: neoplasia of dendritic cells and macrophages. Semin Cell Dev Biol 2019;86:62–76.
Goyal G, Young JR, Koster MJ, et al. The Mayo Clinic histiocytosis working group consensus statement for the diagnosis and evaluation of adult patients with histiocytic neoplasms: Erdheim-Chester disease, Langerhans cell histiocytosis, and Rosai-Dorfman disease. Mayo Clin Proc 2019;94:2054–2071.
- Search Google Scholar
- Export Citation
, Goyal G , Young JR , Koster MJ The Mayo Clinic histiocytosis working group consensus statement for the diagnosis and evaluation of adult patients with histiocytic neoplasms: Erdheim-Chester disease, Langerhans cell histiocytosis, and Rosai-Dorfman disease. Mayo Clin Proc 2019; 94: 2054– 2071. 10.1016/j.mayocp.2019.02.023
Go RS, Jacobsen E, Baiocchi R, et al. NCCN Clinical Practice Guidelines in Oncology: Histiocytic Neoplasms. Version 2. 2021. Accessed September 21, 2021. To view the most recent version, visit NCCN.org